Cetuximab in the treatment of squamous cell carcinoma of the head and neck

P Specenier, JB Vermorken - Expert review of anticancer therapy, 2011 - Taylor & Francis
The majority of the head and neck cancers are squamous cell carcinomas, which commonly
overexpress the EGF receptor (EGFR). Cetuximab is a chimeric monoclonal antibody that …
被引用次数：66 相关文章

[引用][C] Cetuximab in the treatment of squamous cell carcinoma of the head and neck

P Specenier, JB Vermorken - Expert Review of Anticancer Therapy, 2011 - cir.nii.ac.jp
Cetuximab in the treatment of squamous cell carcinoma of the head and neck | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …

Cetuximab in the treatment of squamous cell carcinoma of the head and neck

P Specenier, JB Vermorken - Expert review of anticancer …, 2011 - pubmed.ncbi.nlm.nih.gov
The majority of the head and neck cancers are squamous cell carcinomas, which commonly
overexpress the EGF receptor (EGFR). Cetuximab is a chimeric monoclonal antibody that …

Cetuximab in the treatment of squamous cell carcinoma of the head and neck.

P Specenier, JB Vermorken - Expert Review of Anticancer Therapy, 2011 - europepmc.org
The majority of the head and neck cancers are squamous cell carcinomas, which commonly
overexpress the EGF receptor (EGFR). Cetuximab is a chimeric monoclonal antibody that …

Cetuximab in the treatment of squamous cell carcinoma of the head and neck

P Specenier, JB Vermorken - Expert review of anticancer …, 2011 - repository.uantwerpen.be
The majority of the head and neck cancers are squamous cell carcinomas, which commonly
overexpress the EGF receptor (EGFR). Cetuximab is a chimeric monoclonal antibody that …

Cetuximab in the treatment of squamous cell carcinoma of the head and neck

P Specenier, JB Vermorken - Expert Review of Anticancer …, 2011 - search.proquest.com
The majority of the head and neck cancers are squamous cell carcinomas, which commonly
overexpress the EGF receptor (EGFR). Cetuximab is a chimeric monoclonal antibody that …

Cetuximab in the treatment of squamous cell carcinoma of the head and neck

P Specenier, JB Vermorken - Expert Review of Anticancer Therapy, 2011 - go.gale.com
More than 90% of head and neck cancers are of squamous cell histology and originate in
the lip/oral cavity, nasopharynx, oropharynx, hypopharynx and the larynx. Head and neck …